FDA suspends use of MR vaccine batch
This is the first such action by the FDA despite the government dismissing all reports of post-vaccination illness.
Mumbai: Following the death of a baby following a measles-rubella (MR) vaccination, the Food and Drug Authority (FDA) has directed officials to immediately stop the use of the batch of measles and rubella vaccine, which was used. This is the first such action by the FDA despite the government dismissing all reports of post-vaccination illness.
According to FDA officials, the MR vaccine along with three syringes was used during the vaccination. “We have ordered that the use of the vaccine be stopped, and samples of the drugs be drawn,” said PR Ramteke, drug inspector.
A one-year-old girl died in December last year after she was administered the MR vaccine at the Government Medical College and Hospital in Nagpur.
Astha Godange, was vaccinated at Tumsar tehsil's Garra village on December 15. After the vaccination, she suffered loose motions and was taken to the local hospital. On December 7, an 11-year old girl from Lakhni tehsil in Bhandara district died after developing complications following the MR vaccination.